All In Biotech

Drug Trial Radar · NCT00031161

Prevention of Dichloroacetate Toxicity

Last checked: Nov 19, 2026Latest source record: Mar 25, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Planned (sponsor's estimate)

Start

Sep 2001

Primary completion

Not stated

Study completion Sep 2005

Sponsor

Lead sponsor
University of FloridaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 27, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 3 months, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).

Conditions

  • Acidosis, Lactic
  • Chronic Disease

Interventions

  • Nitisinone (NTBC)Drug

  • DichloroacetateDrug

  • Low-tyrosin dietBehavioral

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Florida

    Gainesville, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.